Treatment of epilepsy in daily clinical practice: have outcomes improved over the past 10&#160;years? (Q48198027)

9 February 2018

title

Treatment of epilepsy in daily clinical practice: have outcomes improved over the past 10 years? (English)

1 reference

9 February 2018

1 reference

9 February 2018

author name string

Inger van Heijl

1 reference

9 February 2018

Frans S S Leijten

1 reference

9 February 2018

Paul van der Linden

1 reference

9 February 2018

Sabine G Uijl

1 reference

9 February 2018

A C G Egberts

1 reference

9 February 2018

J A Carpay

1 reference

9 February 2018

publication date

28 July 2013

1 reference

9 February 2018

published in

Journal of Neurology

1 reference

9 February 2018

volume

260

1 reference

9 February 2018

issue

1 reference

9 February 2018

page(s)

2736-2743

1 reference

9 February 2018

Complaints associated with the use of antiepileptic drugs: results from a community-based study

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7058-0

The use of antiepileptic drugs--principles and practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7058-0

The epidemiology of epilepsy revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7058-0

In search of models of pharmacoresistant epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7058-0

The impact of side effects on long-term retention in three new antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7058-0

Introduction and first validation of EpiTrack Junior, a screening tool for the assessment of cognitive side effects of antiepileptic medication on attention and executive functions in children and adolescents with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7058-0

Standards for epidemiologic studies and surveillance of epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7058-0

European survey of the level of satisfaction of patients and physicians in the management of epilepsy in general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7058-0

The Art of Managing Conversions between Antiepileptic Drugs: Maximizing Patient Tolerability and Quality of Life

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7058-0

What is the role of depressive symptoms among other predictors of quality of life in people with well-controlled epilepsy on monotherapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7058-0

Determinants of health-related quality of life in pharmacoresistant epilepsy: results from a large multicenter study of consecutively enrolled patients using validated quantitative assessments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7058-0

Determinants of quality of life in people with epilepsy and their gender differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7058-0

Factors predictive of resilience and vulnerability in new-onset epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7058-0

Epilepsy in North America: a report prepared under the auspices of the global campaign against epilepsy, the International Bureau for Epilepsy, the International League Against Epilepsy, and the World Health Organization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7058-0

Modern antiepileptic drug development has failed to deliver: Ways out of the current dilemma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7058-0

Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the [...]

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7058-0

The new antiepileptic drugs: scientific review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7058-0

The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7058-0

The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7058-0

New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7058-0

Comparison of antiepileptic drug prescribing in children in three European countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7058-0

Adverse antiepileptic drug effects in new-onset seizures: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7058-0

Drug treatment of epilepsy in the century of the ILAE: the second 50 years, 1959-2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7058-0

Adverse effects of antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7058-0

A cross-sectional study of subjective complaints in patients with epilepsy who seem to be well-controlled with anti-epileptic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7058-0

Development and cross-cultural translations of a 31-item quality of life in epilepsy inventory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7058-0

Dealing with missing outcome data in randomized trials and observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7058-0

When clinical trials make history: demonstrating efficacy of new antiepileptic drugs as monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7058-0

Quality of life of patients with epilepsy living in Kingston, Jamaica

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7058-0

Association of subjective anxiety, depression, and sleep disturbance with quality-of-life ratings in adults with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7058-0

Predictors of health-related quality of life and costs in adults with epilepsy: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7058-0

Intractable childhood epilepsy: choosing between the treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7058-0

Quality of life of people with epilepsy: a European study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7058-0

Coping style and quality of life in patients with epilepsy: a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7058-0

Non-interventional surveillance study of adverse events in patients with epilepsy

21 January 2018

1 reference

12 December 2020

Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/Carbamazepine Monotherapy Trial Group

1 reference

12 December 2020

Epilepsy surveillance among adults--19 States, Behavioral Risk Factor Surveillance System, 2005.

1 reference

12 December 2020

Evidence-based epileptology, randomized controlled trials, and SANAD: a critical clinical view

1 reference

12 December 2020

Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation

1 reference

12 December 2020

10.1007/S00415-013-7058-0

Identifiers

DOI

1 reference

9 February 2018

1 reference

9 February 2018